Portfolio company
SmartDyeLivery
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops functionalised nanocarrier systems for the targeted delivery of pharmaceutical ingredients to treat organ-specific diseases such as septic liver failure.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Smart Vitamins
This company develops nanoencapsulation technology to improve active compound delivery for pharmaceutical, healthcare, nutraceutical and cosmetics customers.
SHIFTBIO
This deep-tech company develops a programmable natural nanoparticle drug delivery platform for pharmaceutical and biotechnology partners to enable targeted therapeutic applications.
NanoSyrinx
NanoSyrinx develops synthetic nanosyringes for targeted intracellular delivery of protein and peptide therapeutics to pharmaceutical and biotechnology companies.
NaDeNo
This company develops a nanotechnology drug delivery platform for pharmaceutical partners to encapsulate hydrophobic small molecule drugs for targeted cancer treatments.
Hemotune
This company develops a magnetic blood purification platform using nanoengineered beads to remove specific disease-causing substances for patients with sepsis or requiring gene therapy.
Nanograb
This company develops an artificial intelligence platform to design targeted gene delivery vectors and nanoparticles for pharmaceutical organisations developing genetic medicines.
Hone Bio
This company develops lipid nanoparticle targeting technology for pharmaceutical and biotechnology firms to enable precise drug delivery beyond the liver.
Phage therapy treatment
This company develops personalised bacteriophage cocktails and diagnostic susceptibility tests for patients suffering from multidrug-resistant bacterial infections.
